Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis.
Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis.
复制标题
DOI:
10.1371/journal.pone.0192895
复制
发表时间:
2018
期刊:
影响因子:
3.7
通讯作者:
Gray LJ
中科院分区:
文献类型:
--
作者:
Major RW;Cheng MRI;Grant RA;Shantikumar S;Xu G;Oozeerally I;Brunskill NJ;Gray LJ
Chronic kidney disease (CKD) is a global health burden and is independently associated with increased cardiovascular disease risk. Assessment of cardiovascular risk in the general population using prognostic models based on routinely collected risk factors is embedded in clinical practice. In CKD, prognostic models may misrepresent risk due to the interplay of traditional atherosclerotic and non-traditional risk factors. This systematic review’s aim was to identify routinely collected risk factors for inclusion in a CKD-specific cardiovascular prognostic model. Systematic review and meta-analysis of observational cohort studies and randomized controlled trials. Studies identified from MEDLINE and Embase searches using a pre-defined and registered protocol (PROSPERO ID—2016:CRD42016036187). The main inclusion criteria were individuals ≥18 years of age with non-endstage CKD. Routinely collected risk factors where multi-variable adjustment for established cardiovascular risk factors had occurred were extracted. The primary outcome was fatal and non-fatal cardiovascular events. The review of 3,232, abstracts identified 29 routinely collected risk factors of which 20 were presented in more than 1 cohort. 21 cohorts were identified in relation to 27,465 individuals and 100,838 person-years. In addition to established traditional general population cardiovascular risk factors, left ventricular hypertrophy, serum albumin, phosphate, urate and hemoglobin were all found to be statistically significant in their association with future cardiovascular events. These non-traditional risk factors should be assessed in the development of future cardiovascular prognostic models for use in individuals with CKD.
登录
查看更多内容
DOI:
10.1136/bmj.f5680
发表时间:
2013-10-03
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Blood Pressure Lowering Treatment Trialists' Collaboration;Ninomiya T;Perkovic V;Turnbull F;Neal B;Barzi F;Cass A;Baigent C;Chalmers J;Li N;Woodward M;MacMahon S
通讯作者:
MacMahon S
影响因子:
6.1
作者:
Chandra, Preeti;Sands, Robin L.;Saran, Rajiv
通讯作者:
Saran, Rajiv
影响因子:
24
作者:
De Nicola, Luca;Gabbai, Francis B.;Minutolo, Roberto
通讯作者:
Minutolo, Roberto
影响因子:
2.3
作者:
Locatelli, Francesco;Eckardt, Kai-Uwe;Drueeke, Tilman B.
通讯作者:
Drueeke, Tilman B.
DOI:
10.2215/cjn.02350213
发表时间:
2013-11-07
影响因子:
9.8
作者:
Chen, Szu-Chia;Hung, Chi-Chih;Chen, Hung-Chun
通讯作者:
Chen, Hung-Chun